First Eagle Investment Management LLC trimmed its position in Tenet Healthcare Co. (NYSE:THC – Free Report) by 25.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,030 shares of the company’s stock after selling 38,575 shares during the quarter. First Eagle Investment Management LLC owned approximately 0.11% of Tenet Healthcare worth $14,903,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the company. Seven Eight Capital LP purchased a new position in shares of Tenet Healthcare during the 2nd quarter valued at $1,130,000. Vanguard Personalized Indexing Management LLC grew its position in Tenet Healthcare by 14.7% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 8,492 shares of the company’s stock worth $1,130,000 after buying an additional 1,091 shares in the last quarter. Mercer Global Advisors Inc. ADV bought a new position in Tenet Healthcare in the 2nd quarter worth about $905,000. Renaissance Technologies LLC bought a new stake in shares of Tenet Healthcare during the 2nd quarter valued at about $27,454,000. Finally, Quantbot Technologies LP bought a new position in shares of Tenet Healthcare in the second quarter worth approximately $3,557,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.
Insiders Place Their Bets
In related news, CEO Saumya Sutaria sold 86,227 shares of the business’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $154.41, for a total transaction of $13,314,311.07. Following the transaction, the chief executive officer now owns 13,773 shares in the company, valued at $2,126,688.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Tenet Healthcare news, CEO Saumya Sutaria sold 86,227 shares of the company’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $154.41, for a total transaction of $13,314,311.07. Following the transaction, the chief executive officer now owns 13,773 shares in the company, valued at approximately $2,126,688.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Meghan Fitzgerald sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $146.34, for a total value of $2,926,800.00. Following the completion of the transaction, the director now owns 15,269 shares of the company’s stock, valued at approximately $2,234,465.46. The disclosure for this sale can be found here. In the last ninety days, insiders sold 128,203 shares of company stock worth $19,754,997. 0.93% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Read Our Latest Stock Report on THC
Tenet Healthcare Stock Performance
Tenet Healthcare stock opened at $161.15 on Thursday. Tenet Healthcare Co. has a 1-year low of $51.04 and a 1-year high of $166.89. The firm has a market cap of $15.74 billion, a P/E ratio of 6.25, a P/E/G ratio of 0.80 and a beta of 2.14. The company has a current ratio of 1.45, a quick ratio of 1.38 and a debt-to-equity ratio of 2.53. The firm has a 50-day moving average of $151.20 and a 200-day moving average of $129.25.
Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $2.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.42. The firm had revenue of $5.10 billion for the quarter, compared to analyst estimates of $4.98 billion. Tenet Healthcare had a return on equity of 24.66% and a net margin of 13.17%. Sell-side analysts expect that Tenet Healthcare Co. will post 10.7 EPS for the current year.
Tenet Healthcare declared that its Board of Directors has authorized a share buyback plan on Wednesday, July 24th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the company to buy up to 10.3% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Articles
- Five stocks we like better than Tenet Healthcare
- Upcoming IPO Stock Lockup Period, Explained
- How Much Can You Make in Stocks in One Month?
- The Risks of Owning Bonds
- This Is the Top Large-Cap Stock Insiders Are Buying
- Insider Buying Explained: What Investors Need to Know
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.